NCT03118284

Brief Summary

Urinary \[Foley\] catheters \[tubes\] are commonly placed in patients undergoing surgery; approximately 25% of surgical patients will receive one. Among patients who receive urinary catheters, discomfort associated with the Foley catheter is common; between 47-90% of patients experience catheter related bladder discomfort \[CRBD\]. Presence of a foreign object in the bladder even for short periods of time may result in symptoms such as a burning sensation, pain in the lower abdomen, muscle spasms and a sense of urgency to urinate. There is some evidence that suggests that hospital-acquired urinary tract infections are directly related to catheter placement, which causes mechanical damage and local inflammation to the urethra and the bladder. Based on research conducted on a similar mechanism where an airway tube is inserted into a patients throat for delivery of general anesthesia - we hypothesize that CRBD is related to injury and inflammation caused by the catheter placement and that this occurs in a sterile environment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 21, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2017

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2017

Completed
Last Updated

November 15, 2018

Status Verified

November 1, 2018

Enrollment Period

9 months

First QC Date

April 5, 2017

Last Update Submit

November 13, 2018

Conditions

Keywords

Foley catheter

Outcome Measures

Primary Outcomes (1)

  • Neutrophil surface marker changes in subjects that experience Foley catheter related bladder discomfort [FCRBD]

    Changes in surface inflammatory markers on polymorphonuclear neutrophils associated with bladder injury secondary to Foley catheter placement.

    Change from baseline [immediately after catheter placement] until catheter removal [post-operative day 1, 2, 3].

Study Arms (2)

Foley catheter group

Urine collection and blood collection and NRS for pain in patients having surgery for which their surgeon has ordered placement of a Foley catheter.

Other: urine collectionOther: Blood collectionBehavioral: NRS

Healthy control group

Blood collection in healthy volunteers from the Research Participant Registry or recruited from posters around the Washington University campus

Other: Blood collection

Interventions

Foley catheter group
Foley catheter groupHealthy control group
NRSBEHAVIORAL
Foley catheter group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients having elective surgery requiring hospitalization and Foley catheter placement.

You may qualify if:

  • Ages 18 to 75.
  • American Society of Anesthesiologists Physical Status Classification (ASA) I, II, and III, per CPAP assessment.
  • Planned Foley catheter placement with surgery and hospitalization.
  • Scheduled elective surgery (i.e., orthopedic, neurosurgical, spine surgery, cardiac, thoracic surgery, ear nose and throat surgery).
  • Anticipated length of Foley catheter requirement up to 72 hours.
  • Ability to provide informed consent.

You may not qualify if:

  • Visible blood in the urine as evident upon sample collection.
  • More than one attempt to place the Foley catheter as documented by RN in OR.
  • Planned surgical procedure involving the urinary system
  • On dialysis and/or anuric
  • Urinary tract infection (UTI) as documented by primary team within 24 hours of surgery
  • Pregnancy or lactating.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University in St Louis

St Louis, Missouri, 63110, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

mtDNA samples isolated from blood and supernatants from urine will be retained and frozen for future research

MeSH Terms

Interventions

Urine Specimen CollectionBlood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative TechniquesPuncturesSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2017

First Posted

April 18, 2017

Study Start

November 21, 2016

Primary Completion

August 21, 2017

Study Completion

August 28, 2017

Last Updated

November 15, 2018

Record last verified: 2018-11

Data Sharing

IPD Sharing
Will not share

Locations